Free Trial

Murphy Middleton Hinkle & Parker Inc. Acquires 115,480 Shares of McKesson Corporation $MCK

McKesson logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Murphy Middleton Hinkle & Parker Inc. bought an additional 115,480 shares of McKesson in Q4, bringing its total to 115,852 shares and making McKesson roughly 26.9% of the firm's portfolio (about $95.0M).
  • McKesson beat Q4 estimates with EPS of $9.34 and revenue of $106.16B, set FY2026 EPS guidance at 38.80–39.20, and announced a quarterly dividend of $0.82 (annualized $3.28).
  • Analysts are broadly positive with a consensus rating of Moderate Buy and an average price target of $960.93, while JPMorgan raised its target to $1,107; institutional investors own about 85% of the stock.
  • Five stocks we like better than McKesson.

Murphy Middleton Hinkle & Parker Inc. lifted its holdings in shares of McKesson Corporation (NYSE:MCK - Free Report) by 31,043.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 115,852 shares of the company's stock after buying an additional 115,480 shares during the quarter. McKesson comprises approximately 26.9% of Murphy Middleton Hinkle & Parker Inc.'s investment portfolio, making the stock its biggest holding. Murphy Middleton Hinkle & Parker Inc. owned about 0.09% of McKesson worth $95,032,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of MCK. SG Americas Securities LLC lifted its holdings in McKesson by 2,030.0% in the fourth quarter. SG Americas Securities LLC now owns 135,766 shares of the company's stock valued at $111,367,000 after buying an additional 129,392 shares during the period. Diversified Trust Co. grew its holdings in McKesson by 5.9% during the 4th quarter. Diversified Trust Co. now owns 5,935 shares of the company's stock worth $4,868,000 after acquiring an additional 332 shares during the period. Charles Schwab Trust Co grew its holdings in McKesson by 13.5% during the 4th quarter. Charles Schwab Trust Co now owns 724 shares of the company's stock worth $594,000 after acquiring an additional 86 shares during the period. 180 Wealth Advisors LLC raised its position in shares of McKesson by 254.1% during the 4th quarter. 180 Wealth Advisors LLC now owns 1,452 shares of the company's stock valued at $1,191,000 after acquiring an additional 1,042 shares during the last quarter. Finally, Dynamic Advisor Solutions LLC lifted its stake in shares of McKesson by 28.4% in the 4th quarter. Dynamic Advisor Solutions LLC now owns 1,118 shares of the company's stock valued at $917,000 after purchasing an additional 247 shares during the period. 85.07% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on MCK shares. JPMorgan Chase & Co. raised their price target on McKesson from $983.00 to $1,107.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 10th. Raymond James Financial set a $970.00 target price on McKesson in a research note on Thursday, March 5th. Zacks Research lowered McKesson from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, November 25th. Leerink Partners reaffirmed an "outperform" rating and issued a $1,085.00 price target on shares of McKesson in a research note on Thursday, March 5th. Finally, Weiss Ratings downgraded shares of McKesson from a "buy (a-)" rating to a "buy (b+)" rating in a research report on Thursday, February 5th. Thirteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, McKesson has a consensus rating of "Moderate Buy" and an average price target of $960.93.

Read Our Latest Stock Analysis on McKesson

McKesson Trading Down 0.8%

Shares of McKesson stock opened at $878.61 on Tuesday. The stock's fifty day simple moving average is $904.74 and its 200 day simple moving average is $835.82. The company has a market capitalization of $107.62 billion, a PE ratio of 25.27, a PEG ratio of 1.43 and a beta of 0.38. McKesson Corporation has a 12 month low of $637.00 and a 12 month high of $999.00.

McKesson (NYSE:MCK - Get Free Report) last posted its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm had revenue of $106.16 billion during the quarter, compared to analysts' expectations of $105.98 billion. During the same period in the previous year, the firm earned $8.03 earnings per share. The company's revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Analysts predict that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be given a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson's payout ratio is currently 9.43%.

Insider Activity

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm's stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Maria Martinez sold 349 shares of McKesson stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the transaction, the director directly owned 301 shares in the company, valued at approximately $282,900.87. The trade was a 53.69% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 3,868 shares of company stock worth $3,743,820. Corporate insiders own 0.08% of the company's stock.

McKesson Company Profile

(Free Report)

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Read More

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in McKesson Right Now?

Before you consider McKesson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.

While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines